Senseonics Holdings, Inc. (SENS) Investor Relations Documents
Senseonics Holdings, Inc. (SENS) investor relations documents from the company's IR site: 4 presentations, 16 press releases; latest deck 2025-11-13. Read in-app with summaries. First-party data.
https://www.senseonics.com/~/media/Files/S/Senseonics-IR/reports-and-presentations/sens-investor-deck-november-2025.pdf — Senseonics November 2025 investor presentation outlines its strategy to capture share in the $13.5B CGM market, reporting 160% year-over-year new patient growth.
Investor relations documents — source: company IR site| Published | Type | Document |
|---|
| 2026-06-06 | Press release | Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open a |
| 2026-06-01 | Press release | Senseonics Highlights Analyst Event and Oral Presentation of Eversense 365 Real-World Evidence at ADA 2026 |
| 2026-05-04 | Press release | Senseonics Announces Closing of $92 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additi |
| 2026-05-04 | Press release | Senseonics Enters Into Amended Loan Agreement with Hercules to Increase Borrowing Capacity to $140 Million |
| 2026-05-01 | Press release | Senseonics Holdings, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call for May 7, 2026 at 4:30 P.M. |
| 2026-04-30 | Press release | Senseonics Announces Pricing of $80 Million Public Offering of Common Stock and Pre-Funded Warrants |
| 2026-04-30 | Press release | Senseonics Announces Commencement of $80 Million Public Offering of Common Stock and Pre-Funded Warrants |
| 2026-04-24 | Press release | Senseonics Announces European Launch of Eversense® 365, The World’s First and Only One Year CGM System |
| 2026-03-14 | Press release | First Ever Real-World Evidence of Eversense 365 Presented at ATTD Demonstrates Sustained Performance and Positive Impact |
| 2026-02-19 | Press release | Sequel Med Tech and Senseonics Launch Transformative Combination of twiist™ and Eversense® 365 |
| 2026-01-29 | Press release | Senseonics Receives European Approval for Eversense 365, World’s Longest-lasting Continuous Glucose Monitor |
| 2026-01-28 | Press release | Senseonics Holdings, Inc. to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tool |
| 2026-01-12 | Press release | PDF, 205KB, opens in a new window |
| 2026-01-12 | Press release | Senseonics Announces Preliminary Unaudited Revenue for Fourth Quarter 2025 and Provides Business Update |
| 2026-01-08 | Press release | PDF, 57KB, opens in a new window |
| 2026-01-08 | Press release | Senseonics Announces First Commercial Patients Using Eversense 365 Continuous Glucose Monitor (CGM) with twiist™ Automat |
| 2025-11-13 | Presentation | https://www.senseonics.com/~/media/Files/S/Senseonics-IR/reports-and-presentations/sens-investor-deck-november-2025.pdf |
| 2025-06-23 | Presentation | View presentation |
| 2023-06-01 | Presentation | View presentation |
| 2020-09-15 | Presentation | View presentation |
SENS overview · SENS earnings · SENS financials · SENS KPIs · SENS ownership · SENS peers · SENS filings
Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.